Cecil D. Haney - 27 May 2026 Form 4 Insider Report for TENET HEALTHCARE CORP (THC)

Reporting relationship: Director
Issuer ticker: THC
Reported as of: 27 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 28 May 2026, 20:00:09 UTC
Prior SEC filing: 26 May 2026
Next SEC filing: 18 Jun 2026
Source filing: View source filing
Reporting owner signature: Chad J. Wiener, as Attorney-in-fact for Cecil D. Haney

Key filing fact

Cecil D. Haney filed Form 4 for TENET HEALTHCARE CORP (THC) on 28 May 2026.

Key facts

This page summarizes Cecil D. Haney's Form 4 filing for TENET HEALTHCARE CORP (THC).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 28 May 2026, 20:00.

Change

Previous filing in this sequence was filed on 26 May 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001769664 Primary reporting owner

HANEY CECIL D

Relationship: Director
Address: 14201 DALLAS PARKWAY, DALLAS
Signature: Chad J. Wiener, as Attorney-in-fact for Cecil D. Haney
Signature date: 28 May 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

THC transaction Derivative

2026 May Restricted Stock Units

Award

Transaction value
Shares: +1,188
Change %
Price: $0.000000^*
Shares after: 1,188
Date: 27 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,188
Exercise price
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents restricted stock units granted under the Company's Stock Incentive Plan. Each restricted stock unit is the economic equivalent of one share of the Company's common stock. These restricted stock units vest on the first anniversary of the date of grant. The reporting person may elect to receive up to 37% of these restricted stock units in cash in lieu of shares.